Researchers at the Jacobs School of Medicine and Biomedical Sciences have published a study detailing patterns of brain atrophy for patients with multiple sclerosis (MS) and other neurological diseases who are now living longer.
Three Jacobs School of Medicine and Biomedical Sciences faculty members wrote a chapter in the book “Neurological Disorders and Imaging Physics, Volume 3: Application to Autism Spectrum Disorders and Alzheimer’s.”
Fifteen students in the MD-PhD program at the Jacobs School of Medicine and Biomedical Sciences presented posters at the Tri-Institutional MD-PhD Research Day last fall at the Jacobs School building in downtown Buffalo.
A UB spinoff company that is developing a low-cost blood test to screen high-risk patients for unruptured brain aneurysms has received $750,000 Phase II Small Business Innovation Research (SBIR) funding from the National Science Foundation (NSF).
The University at Buffalo has officially launched the UB Biorepository, a critical new facility in the Clinical and Translational Research Center that will serve as a powerful resource in driving biomedical innovation in academia and industry regionally and throughout the state.
Atrophied brain lesion volume is the only marker from MRI scans that can accurately predict which patients will progress to the most severe form of multiple sclerosis (MS), according to a retrospective, five-year study of 1,314 MS patients.